Healthcare
Viemed Healthcare, Inc.(VMD)
Live Price
Offline$10.64
+1.04% today
1Y Change
+56.67%
Window
Jun 23, 2025 โ Jun 12, 2026
- Market Cap
- $360.00M
- Revenue Growth
- +20.5%
- EPS Growth
- +31.0%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Viemed Healthcare, Inc. (VMD) is a Healthcare stock with a market cap of $360.00M and listed on NASDAQ. The stock last traded around $10.64 and up 56.7% across the available one-year price window (Jun 23, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +20.5%, EPS growth of +31.0%, a dividend yield of 0.0%. What stands out right now is revenue +20.5%, EPS +31.0%, free cash flow +805.2% with operating margin 8.1% and ROIC 8.8%. Valuation is more restrained than many high-expectation growth names at P/E 24.1 and price/sales 1.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines VMD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+20.5% vs +7.6% peer median
Operating Margin
Below sector median
+8.1% vs +19.4% peer median
P/E
Below sector median
24.1 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +20.5% and EPS at +31.0%, with operating margin around 8.1%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +4.4% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | +8.2% | +11.5% | +15.6% |
2026 Mar 4, 2026 | +16.7% | -7.5% | +0.0% | +5.6% |
2025 Nov 5, 2025 | +0.0% | -2.6% | +1.9% | +5.3% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VMD
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
VMD Max Drawdown
-17.06%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for VMD and SPY.
Company Overview
Viemed Healthcare, Inc.
NASDAQ Capital Market
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
- Leadership
- Casey Hoyt
- IPO Date
- Aug 9, 2019
- Employees
- 1.2k
- Street Address
- 625 East Kaliste Saloom Road
- Mailing
- Lafayette, LA, 70508
- Region
- Lafayette, LA, US
- Reporting Currency
- USD
- Investor Line
- 337 504 3802
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 24.1
- EV/EBITDA
- 7.1
- Price/Sales
- 1.3
- Price/Book
- 2.5
Growth
- Revenue
- +20.5%
- EPS
- +31.0%
- Free Cash Flow
- +805.2%
Profitability
- Gross Margin
- 57.0%
- Operating Margin
- 8.1%
- Net Margin
- 5.5%
- ROE
- 10.9%
- ROIC
- 8.8%
Balance Sheet
- Debt/Equity
- 0.11
- Current Ratio
- 1.18
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.